Related references
Note: Only part of the references are listed.Clinical Impact of the Immune Microenvironment in Spinal Chordoma: Immunoscore as an Independent Favorable Prognostic Factor
Ming-Xiang Zou et al.
NEUROSURGERY (2019)
Comprehensive analysis of the characteristics and treatment outcomes of patients with non-small cell lung cancer treated with anti-PD-1 therapy in real-world practice
Beung-Chul Ahn et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
Chinese guidelines for the diagnosis and comprehensive treatment of colorectal liver metastases (version 2018)
Jianmin Xu et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
Altered frequency of CD8+CD11c+ T cells and expression of immunosuppressive molecules in lymphoid organs of mouse model of colorectal cancer
Davood Rostamzadeh et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
An Immunoscore Using PD-L1, CD68, and Tumor-infiltrating Lymphocytes (TILs) to Predict Response to Neoadjuvant Chemotherapy in Invasive Breast Cancer
Lauren E. McLemore et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2018)
Progression of Colorectal Cancer Liver Metastasis After Chemotherapy: A New Test of Time?
Eve Simoneau et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Predictive and prognostic clinical and pathological factors of nivolumab efficacy in non-small-cell lung cancer patients
J. Garde-Noguera et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2018)
Tumour YAP1 and PTEN expression correlates with tumour-associated myeloid suppressor cell expansion and reduced survival in colorectal cancer
Rong Yang et al.
IMMUNOLOGY (2018)
International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
Franck Pages et al.
LANCET (2018)
Metastatic site as a predictor of nivolumab efficacy in patients with advanced non-small cell lung cancer: A retrospective multicenter trial
Motohiro Tamiya et al.
PLOS ONE (2018)
Evolution of Metastases in Space and Time under Immune Selection
Mihaela Angelova et al.
CELL (2018)
Integrin CD11b activation drives anti-tumor innate immunity
Michael C. Schmid et al.
NATURE COMMUNICATIONS (2018)
Immune checkpoint inhibitors: recent progress and potential biomarkers
Pramod Darvin et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
The Immunoscore system predicts prognosis after liver metastasectomy in colorectal cancer liver metastases
Yun Wang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
PI3K/Akt/mTOR Signaling and Plasma Membrane Proteins Are Implicated in Responsiveness to Adjuvant Dendritic Cell Vaccination for Metastatic Colorectal Cancer
David C. Qian et al.
CLINICAL CANCER RESEARCH (2017)
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
Sydney R. Gordon et al.
NATURE (2017)
Liver Metastasis and Treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLC
Paul C. Tumeh et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Peripheral and local predictive immune signatures identified in a phase II trial of ipilimumab with carboplatin/paclitaxel in unresectable stage III or stage IV melanoma
Rahima Jamal et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Evaluation of clinicopathological factors in PD-1 response: derivation and validation of a prediction scale for response to PD-1 monotherapy
Adi Nosrati et al.
BRITISH JOURNAL OF CANCER (2017)
Number of Intratumoral T Lymphocytes Is Associated With Lymph Node Size, Lymph Node Harvest, and Outcome in Node-Negative Colon Cancer
Bruno Maerkl et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2016)
Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients
Niels Halama et al.
CANCER CELL (2016)
Increased Levels of Circulating and Tumor-Infiltrating Granulocytic Myeloid Cells in Colorectal Cancer Patients
Salman M. Toor et al.
FRONTIERS IN IMMUNOLOGY (2016)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
D. T. Le et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
CD11b deficiency suppresses intestinal tumor growth by reducing myeloid cell recruitment
Qian-Qian Zhang et al.
SCIENTIFIC REPORTS (2015)
The clinical utility of the local inflammatory response in colorectal cancer
Colin H. Richards et al.
EUROPEAN JOURNAL OF CANCER (2014)
Liver metastases induce reversible hepatic B cell dysfunction mediated by Gr-1+CD11b+ myeloid cells
Mitchell Thorn et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2014)
Tumor-infiltrating lymphocytes in colorectal tumors display a diversity of T cell receptor sequences that differ from the T cells in adjacent mucosal tissue
Anna M. Sherwood et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Elevated CD3+ and CD8+ tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level
Justyna Kmiecik et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics
Andrea Sottoriva et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Expression of chemokine receptor CCR5 correlates with the presence of hepatic molecular metastases in K-ras positive human colorectal cancer
Carl C. Schimanski et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2011)
The atheroprotective mediators apolipoproteinA-I and Foxp3 are over-abundant in unstable carotid plaques
S. Patel et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2010)
Current management of colorectal hepatic metastasis
Skye C Mayo et al.
Expert Review of Gastroenterology & Hepatology (2009)
Strategies to treat primary unresectable colorectal liver metastases
E Vibert et al.
SEMINARS IN ONCOLOGY (2005)
T cell development in mice expressing CD1d directed by a classical MHC class II promoter
C Forestier et al.
JOURNAL OF IMMUNOLOGY (2003)
Share Paper
